Earnings Call · Q2 FY2021·2021-08-04

Q2 21EPS +100.00%*·Rev n/aQ1 21EPS -54.17%·Rev n/aQ4 20EPS +9.62%·Rev n/aQ3 20EPS +100.00%*·Rev n/a⚠ consensus missing

SUPERNUS PHARMACEUTICALS, INC. SUPN

Peter Vozzo — Chief Financial Officer

Jack Khattar — Chief Executive Officer

Jim Kelly — Chief Accounting Officer

−2.2%1d on move date−2.8% vs SPY3d−5.3%5d−9.7%

Research tier

Behavioral profile computed for 3 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more SUPN calls or request research access.

More SUPN calls Browse calls Request research access